Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.

Developing antiviral vaccines is increasingly challenging due to associated time and cost of production as well as emerging drug-resistant strains. A computer-aided vaccine design strategy is presented that could greatly accelerate the discovery process and yield vaccines with high immunogenicity and thermal stability. Our strategy is based on foreign viral epitopes engineered onto well-established virus-like particles (VLPs) and demonstrates that such constructs present similar affinity for antibodies as does a native virus. This binding affinity serves as one molecular metric of immunogenicity. As a demonstration, we engineered a preS1 epitope of hepatitis B virus (HBV) onto the EF loop of human papillomavirus VLP (HPV-VLP). HBV-associated HzKR127 antibody displayed binding affinity for this structure at distances and strengths similar to those for the complex of the antibody with the full HBV (PDBID: 2EH8). This antibody binding affinity assessment, along with other molecular immunogenicity metrics, could be a key component of a computer-aided vaccine design strategy.

[1]  I. Carletti,et al.  Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years , 2009, Human vaccines.

[2]  Daron G Ferris,et al.  The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay , 2011, Human vaccines.

[3]  P. Ortoleva,et al.  Nanosystem self-assembly pathways discovered via all-atom multiscale analysis. , 2012, The journal of physical chemistry. B.

[4]  Laxmikant V. Kale,et al.  Algorithmic Challenges in Computational Molecular Biophysics , 1999 .

[5]  T. Miyamura,et al.  Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. , 2004, Vaccine.

[6]  Peter Ortoleva,et al.  A molecular dynamics study of loop fluctuation in human papillomavirus type 16 virus-like particles: a possible indicator of immunogenicity. , 2011, Vaccine.

[7]  D. Baker,et al.  Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold , 2011, Science.

[8]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[9]  Marianne Manchester,et al.  Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[10]  Jens Meiler,et al.  ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. , 2011, Methods in enzymology.

[11]  K. Jansen,et al.  Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). , 2006, Journal of pharmaceutical sciences.

[12]  Yuriy V Sereda,et al.  Multiscale simulation of microbe structure and dynamics. , 2011, Progress in biophysics and molecular biology.

[13]  Martin Müller,et al.  A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response , 2008, Journal of Virology.

[14]  G. Jennings,et al.  Immunodrugs: therapeutic VLP-based vaccines for chronic diseases. , 2009, Annual review of pharmacology and toxicology.

[15]  David A. Anderson,et al.  Virus-like particles: Passport to immune recognition , 2006, Methods.

[16]  P. Ortoleva,et al.  Hierarchical Multiscale Modeling of Macromolecules and their Assemblies. , 2013, Soft matter.

[17]  Yinglong Miao,et al.  Space warping order parameters and symmetry: application to multiscale simulation of macromolecular assemblies. , 2012, The journal of physical chemistry. B.

[18]  Erwin Sablon,et al.  Advances in Molecular Diagnosis of HBV Infection and Drug Resistance , 2005, International journal of medical sciences.

[19]  Quasiperiodic oscillation and possible Second Law violation in a nanosystem , 2013 .

[20]  M. Nowak.  Immune Responses against Multiple Epitopes: a Theory for Immunodominance and Antigenic Variation Competition between Ctl Epitopes: the Competitive Exclusion Principle , 2022 .

[21]  T. Liang.  Hepatitis B: The virus and disease , 2009, Hepatology.

[22]  Remo Rohs,et al.  Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations , 2005, Nucleic acids research.

[23]  P. Alves,et al.  Large-scale production and purification of VLP-based vaccines , 2011, Journal of Invertebrate Pathology.

[24]  P. Ortoleva,et al.  Variational methods for time-dependent classical many-particle systems. , 2013, Physica A.

[25]  M. Klein,et al.  Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins , 2007, Journal of Biological Chemistry.

[26]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[27]  A Singharoy,et al.  Order parameters for macromolecules: application to multiscale simulation. , 2011, The Journal of chemical physics.

[28]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[29]  Abhishek Singharoy,et al.  Multiscale Macromolecular Simulation: Role of Evolving Ensembles , 2012, J. Chem. Inf. Model..

[30]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[31]  Shina Caroline Lynn Kamerlin,et al.  Computational Protein Engineering: Bridging the Gap between Rational Design and Laboratory Evolution , 2012, International journal of molecular sciences.

[32]  Xiaojiang S. Chen,et al.  Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly , 2007, Virology Journal.

[33]  M. Rami Reddy,et al.  Free energy calculations in rational drug design , 2001 .

[34]  Søren B. Padkjær,et al.  Structural analysis of B-cell epitopes in antibody:protein complexes. , 2013, Molecular immunology.

[35]  S. Ryu,et al.  Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism , 2007, Proceedings of the National Academy of Sciences.

[36]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[37]  F. Zoulim,et al.  Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[38]  P. Coursaget,et al.  Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. , 2003, Virology.

[39]  B. Mumey,et al.  Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. , 2012, Biochimica et biophysica acta.

[40]  E. Walsh,et al.  Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres , 2009, Virology Journal.

[41]  D. Lowy,et al.  Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. , 2000, Virology.

[42]  Peter J Ortoleva,et al.  Hierarchical Order Parameters for Macromolecular Assembly Simulations I: Construction and Dynamical Properties of Order Parameters. , 2012, Journal of chemical theory and computation.

[43]  P. Ortoleva,et al.  Thermal nanostructure: an order parameter multiscale ensemble approach. , 2010, The Journal of chemical physics.

[44]  M. Jarrold,et al.  Discovering free energy basins for macromolecular systems via guided multiscale simulation. , 2012, The journal of physical chemistry. B.

[45]  L. Xing,et al.  Essential Elements of the Capsid Protein for Self-Assembly into Empty Virus-Like Particles of Hepatitis E Virus , 2005, Journal of Virology.

[46]  William R. Jacobs,et al.  Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV , 2012, Cell.